The STAT3 signaling pathway is involved in thyroid cancer aggravated by obesity-related metabolic changes [17] and may be a potential therapeutic target in thyroid cancer. The gene discussed is STAT3; the disease is obesity due to melanocortin 4 receptor deficiency.